Trials / Recruiting
RecruitingNCT07030062
Echocardiography Guided TAVR (Echo TAVR)
Transcatheter Aortic Valve Replacement With Echocardiography Guidance
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (estimated)
- Sponsor
- Pan Xiangbin · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Conventional transcatheter aortic valve replacement (TAVR) relies on fluoroscopic and contrast agents. However, in high-risk patients, exposure to ionizing radiation and contrast agents is contraindicated and undesirable. Echocardiography guidance TAVR can offer a feasible and safer strategy for TAVR.
Conditions
Timeline
- Start date
- 2025-02-18
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2025-06-19
- Last updated
- 2025-06-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07030062. Inclusion in this directory is not an endorsement.